<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00326001</url>
  </required_header>
  <id_info>
    <org_study_id>EP016</org_study_id>
    <nct_id>NCT00326001</nct_id>
  </id_info>
  <brief_title>Isthmus Ablation With Gold Electrode for Treatment of Atrial Flutter (AURUM 8)</brief_title>
  <official_title>AURUM 8 - Ablation of the Cavotricuspid Isthmus in Patients With Atrial Flutter Using an 8 mm Gold Alloy Tip Electrode</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biotronik SE &amp; Co. KG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biotronik SE &amp; Co. KG</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to demonstrate the advantage of using a gold alloy tip electrode
      over a platinum/iridium alloy tip electrode in ablation of the cavotricuspid isthmus in
      patients with atrial flutter.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Transvenous catheter ablation has become the therapy of choice for patients with recurring,
      isthmus-dependent right atrial flutter. Achieving bidirectional conduction block in the
      cavotricuspid isthmus is decisive for both acute and long-term therapy success and
      essentially depends on the selected ablation method and the lesion size. By using an 8 mm tip
      electrode instead of a conventional 4 mm electrode, deeper lesions can be made, thus
      significantly reducing the required number of energy applications for achieving a
      bidirectional conduction block. Experimental studies have proven that using an ablation
      electrode made of gold alloy allows the creation of deeper lesions than with conventional
      platinum-iridium electrodes. Due to the greater heat conductivity of the gold alloy as
      opposed to platinum-iridium, the cooling of the ablation electrode is improved and more
      electric energy can be transmitted to the tissue at identical temperatures.

      The combination of both technologies in the form of an 8 mm-long gold electrode anticipates
      that the lesion depth required for an isthmus block can be achieved more quickly in
      comparison to the platinum-iridium electrode.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2004</start_date>
  <completion_date type="Actual">March 2008</completion_date>
  <primary_completion_date type="Actual">March 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of Energy Application</measure>
    <time_frame>ablation procedure</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ablation Success With the First Catheter</measure>
    <time_frame>ablation procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients With Long-term Treatment Success</measure>
    <time_frame>6 months after ablation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients With Charred Catheter Tips</measure>
    <time_frame>ablation procedure</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">463</enrollment>
  <condition>Atrial Flutter</condition>
  <arm_group>
    <arm_group_label>Gold tip catheter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Gold tip catheter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Platinum-iridium tip catheter</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Platinum-iridium tip catheter</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Gold tip catheter</intervention_name>
    <description>Radiofrquency ablation using gold tip catheter</description>
    <arm_group_label>Gold tip catheter</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Platinum-iridium tip catheter</intervention_name>
    <description>Radiofrequency ablation using platinum-iridium tip catheter</description>
    <arm_group_label>Platinum-iridium tip catheter</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  At least one electrocardiogram (ECG)-documented (can be older than 3 months),
             symptomatic, typical atrial flutter episode with either negative, sawtooth-shaped
             P-waves in leads II, III, and augmented voltage foot (aVF), or positive P-waves in
             leads II, III, and aVF

          -  At least one persistent, typical atrial flutter episode of over 2 hours that has been
             documented in the history in the patient file and/or ECG

          -  Signed informed consent form

        Exclusion Criteria:

          -  Patient has recently undergone isthmus ablation

          -  Acute coronary syndrome or myocardial infarction within the last 3 months

          -  Acute reversible causes for atrial flutter (e.g. acute myocarditis)

          -  Severe cardiac valvular defects

          -  Tricuspid valve replacement

          -  Atrial septum defect

          -  Cardiovascular surgery scheduled within the next 6 months

          -  Unstable medication in the last 7 days before study inclusion

          -  New York Heart Association (NYHA) class IV

          -  Women who are breastfeeding

          -  Pregnancy

          -  Abuse of drugs or alcohol

          -  Patient is unable to participate in follow-up examinations

          -  The patient has only partial legal competence

          -  Participation in another clinical study

          -  The ablation procedure presents an above average risk to the patient as compared to
             the normal patient group (must be noted by the physician on the appropriate form).

          -  Right atrial thrombus

        Late Exclusion Criteria:

          -  Patient included by accident

          -  Premature termination of the ablation procedure

          -  Atrial flutter not dependent on the posterior isthmus

          -  No conduction at the posterior isthmus before ablation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thorsten Lewalter, Assoc. Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitätsklinikum Bonn, Medizinische Klinik and Poliklinik II, Sigmund-Freud-Strasse 25, D-53105 Bonn, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institute of Clinical and Experimental Medicine</name>
      <address>
        <city>Praha</city>
        <zip>14021</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinik der RWTH Aachen</name>
      <address>
        <city>Aachen</city>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kerckhoff Klinik</name>
      <address>
        <city>Bad Nauheim</city>
        <zip>61231</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charité Campus Mitte, Medizinische Fakultät der Humboldt Universität zu Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vivantes Klinikum Am Urban</name>
      <address>
        <city>Berlin</city>
        <zip>10967</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Charité, Campus Benjamin Franklin</name>
      <address>
        <city>Berlin</city>
        <zip>12200</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Charité, Campus Buch Franz-Volhard-Klinik</name>
      <address>
        <city>Berlin</city>
        <zip>13125</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Charité, Campus Virchow-Klinikum</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Berufsgenossenschaftliche Kliniken, Bergmannsheil Universitätsklinik</name>
      <address>
        <city>Bochum</city>
        <zip>44789</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medizinische Einrichtungen der Rheinischen Friedrich-Wilhelms-Universität Bonn</name>
      <address>
        <city>Bonn</city>
        <zip>53105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Elektrophysiologische Praxis am Zentralkrankenhaus Links Der Weser</name>
      <address>
        <city>Bremen</city>
        <zip>28277</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Evangelisches Krankenhaus Düsseldorf</name>
      <address>
        <city>Duesseldorf</city>
        <zip>40217</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herzzentrum Duisburg</name>
      <address>
        <city>Duisburg</city>
        <zip>47137</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Georg-August-Universität, Universitätsklinikum Göttingen</name>
      <address>
        <city>Goettingen</city>
        <zip>37099</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Hamburg-Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Allgemeines Krankenhaus Altona</name>
      <address>
        <city>Hamburg</city>
        <zip>22763</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätskliniken des Saarlandes</name>
      <address>
        <city>Homburg/Saar</city>
        <zip>66421</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Vincentius Krankenhaus/St. Marien Krankenhaus - Abteilung für Innere Medizin III</name>
      <address>
        <city>Karlsruhe</city>
        <zip>76137</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herzzentrum Leipzig GmbH</name>
      <address>
        <city>Leipzig</city>
        <zip>04289</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Mainz</name>
      <address>
        <city>Mainz</city>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Städtisches Krankenhaus München-Bogenhausen</name>
      <address>
        <city>München</city>
        <zip>81925</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Ulm</name>
      <address>
        <city>Ulm</city>
        <zip>89070</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum der Stadt Villingen-Schwenningen GmbH</name>
      <address>
        <city>Villingen-Schwenningen</city>
        <zip>78050</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medizinische Universitätsklinik Würzburg</name>
      <address>
        <city>Würzburg</city>
        <zip>97080</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Semmelweis Medical University - Department of Cardiology</name>
      <address>
        <city>Budapest</city>
        <zip>1122</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Debrecen University of Medicine, Center of Medicine and Health Care Sciences, Clinical Department of Cardiology</name>
      <address>
        <city>Debrecen</city>
        <zip>4032</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The University of Pecs</name>
      <address>
        <city>Pecs</city>
        <zip>7624</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czech Republic</country>
    <country>Germany</country>
    <country>Hungary</country>
  </location_countries>
  <reference>
    <citation>Lewalter T, Bitzen A, Wurtz S, Blum R, Schlodder K, Yang A, Lickfett L, Schwab JO, Schrickel JW, Tiemann K, Linhart M, Zima E, Merkely B, Lüderitz B. Gold-tip electrodes--a new &quot;deep lesion&quot; technology for catheter ablation? In vitro comparison of a gold alloy versus platinum-iridium tip electrode ablation catheter. J Cardiovasc Electrophysiol. 2005 Jul;16(7):770-2.</citation>
    <PMID>16050836</PMID>
  </reference>
  <reference>
    <citation>Berjano EJ. Gold-tip electrodes--a new 'deep lesion' technology for catheter ablation? In vitro comparison of gold alloy versus platinum-iridium tip electrode ablation catheter. J Cardiovasc Electrophysiol. 2005 Dec;16(12):1395-6.</citation>
    <PMID>16403084</PMID>
  </reference>
  <verification_date>August 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 12, 2006</study_first_submitted>
  <study_first_submitted_qc>May 12, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 16, 2006</study_first_posted>
  <results_first_submitted>May 13, 2009</results_first_submitted>
  <results_first_submitted_qc>January 8, 2010</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 4, 2010</results_first_posted>
  <last_update_submitted>February 3, 2010</last_update_submitted>
  <last_update_submitted_qc>February 3, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 18, 2010</last_update_posted>
  <keyword>Transvenous Catheter Ablation</keyword>
  <keyword>Radiofrequency Catheter Ablation</keyword>
  <keyword>Atrial flutter</keyword>
  <keyword>Catheter Ablation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Flutter</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>A total of 463 patients were enrolled in the AURUM 8 study from June 2004 to March 2007 in 19 clinical centers in Germany and the Czech Republic.</recruitment_details>
      <pre_assignment_details>No exclusion before assignment</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Gold Tip Catheter</title>
          <description>Patients allocated to be ablated by 8-mm gold tip catheter</description>
        </group>
        <group group_id="P2">
          <title>Pt-Ir Tip Catheter</title>
          <description>Patients allocated to be ablated by 8-mm Platinum-Iridium tip catheter</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="236"/>
                <participants group_id="P2" count="227"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="229"/>
                <participants group_id="P2" count="219"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Gold Tip Catheter</title>
          <description>Patients allocated to be ablated by 8-mm gold tip catheter</description>
        </group>
        <group group_id="B2">
          <title>Pt-Ir Tip Catheter</title>
          <description>Patients allocated to be ablated by 8-mm Platinum-Iridium tip catheter</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="236"/>
            <count group_id="B2" value="227"/>
            <count group_id="B3" value="463"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="97"/>
                    <measurement group_id="B2" value="92"/>
                    <measurement group_id="B3" value="189"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="139"/>
                    <measurement group_id="B2" value="135"/>
                    <measurement group_id="B3" value="274"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66" spread="10"/>
                    <measurement group_id="B2" value="66" spread="11"/>
                    <measurement group_id="B3" value="66" spread="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45"/>
                    <measurement group_id="B2" value="35"/>
                    <measurement group_id="B3" value="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="191"/>
                    <measurement group_id="B2" value="192"/>
                    <measurement group_id="B3" value="383"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Czech Republic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Germany</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="227"/>
                    <measurement group_id="B2" value="219"/>
                    <measurement group_id="B3" value="446"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Duration of Energy Application</title>
        <description>Cumulative amount of time current is flowing through the catheter tip. The current (in the radiofrequency range) is applied to ablate the cavotricuspid isthmus in the right atrium.</description>
        <time_frame>ablation procedure</time_frame>
        <population>Per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>Gold Tip Catheter</title>
            <description>Patients allocated to be ablated by 8-mm gold tip catheter</description>
          </group>
          <group group_id="O2">
            <title>Pt-Ir Tip Catheter</title>
            <description>Patients allocated to be ablated by 8-mm Platinum-Iridium tip catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Duration of Energy Application</title>
          <description>Cumulative amount of time current is flowing through the catheter tip. The current (in the radiofrequency range) is applied to ablate the cavotricuspid isthmus in the right atrium.</description>
          <population>Per protocol</population>
          <units>minute</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="229"/>
                <count group_id="O2" value="219"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.2" spread="6.9"/>
                    <measurement group_id="O2" value="10.9" spread="6.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.25</p_value>
            <p_value_desc>P-value not adjusted for multiple comparisons</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ablation Success With the First Catheter</title>
        <description>Delivery of radiofrequency current was repeated until a cavotricuspid isthmus (CTI) conduction block was detected. The final bidirectional CTI block test (well documented in the literature) was performed 20 minutes after the last radiofrequency current delivery to assess ablation success (Y/N).
Positive final bidirectional cavotricuspid isthmus condution block test means &quot;ablation successful&quot;.
Negative final bidirectional cavotricuspid isthmus condution block test means &quot;ablation unsuccessful&quot;; ablation should be continued until success or terminated and classified as unsuccess.</description>
        <time_frame>ablation procedure</time_frame>
        <population>per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>Gold Tip Catheter</title>
            <description>Patients allocated to be ablated by 8-mm gold tip catheter</description>
          </group>
          <group group_id="O2">
            <title>Pt-Ir Tip Catheter</title>
            <description>Patients allocated to be ablated by 8-mm Platinum-Iridium tip catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Ablation Success With the First Catheter</title>
          <description>Delivery of radiofrequency current was repeated until a cavotricuspid isthmus (CTI) conduction block was detected. The final bidirectional CTI block test (well documented in the literature) was performed 20 minutes after the last radiofrequency current delivery to assess ablation success (Y/N).
Positive final bidirectional cavotricuspid isthmus condution block test means &quot;ablation successful&quot;.
Negative final bidirectional cavotricuspid isthmus condution block test means &quot;ablation unsuccessful&quot;; ablation should be continued until success or terminated and classified as unsuccess.</description>
          <population>per protocol</population>
          <units>Patients</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="229"/>
                <count group_id="O2" value="219"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="216"/>
                    <measurement group_id="O2" value="195"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.042</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients With Long-term Treatment Success</title>
        <description>No recurrence of atrial flutter after ablation</description>
        <time_frame>6 months after ablation</time_frame>
        <population>per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>Gold Tip Catheter</title>
            <description>Patients allocated to be ablated by 8-mm gold tip catheter</description>
          </group>
          <group group_id="O2">
            <title>Pt-Ir Tip Catheter</title>
            <description>Patients allocated to be ablated by 8-mm Platinum-Iridium tip catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients With Long-term Treatment Success</title>
          <description>No recurrence of atrial flutter after ablation</description>
          <population>per protocol</population>
          <units>Patients</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="229"/>
                <count group_id="O2" value="219"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="225"/>
                    <measurement group_id="O2" value="213"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.53</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients With Charred Catheter Tips</title>
        <description>Char or coagulum formation on the catheter tip</description>
        <time_frame>ablation procedure</time_frame>
        <population>per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>Gold Tip Catheter</title>
            <description>Patients allocated to be ablated by 8-mm gold tip catheter</description>
          </group>
          <group group_id="O2">
            <title>Pt-Ir Tip Catheter</title>
            <description>Patients allocated to be ablated by 8-mm Platinum-Iridium tip catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients With Charred Catheter Tips</title>
          <description>Char or coagulum formation on the catheter tip</description>
          <population>per protocol</population>
          <units>Patients</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="229"/>
                <count group_id="O2" value="219"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Gold Tip Catheter</title>
          <description>Patients allocated to be ablated by 8-mm gold tip catheter</description>
        </group>
        <group group_id="E2">
          <title>Pt-Ir Tip Catheter</title>
          <description>Patients allocated to be ablated by 8-mm Platinum-Iridium tip catheter</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="229"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="219"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Death</sub_title>
                <description>Death for any cause</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="229"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="219"/>
              </event>
              <event>
                <sub_title>Hospitalization</sub_title>
                <description>Hospitalization for any cause</description>
                <counts group_id="E1" events="18" subjects_affected="18" subjects_at_risk="229"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="219"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="229"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="219"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dejan Danilovic</name_or_title>
      <organization>Biotronik GmbH&amp;Co. KG, Berlin, Germany</organization>
      <phone>+49 9131 8924 7832</phone>
      <email>dejan.danilovic@biotronik.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

